Ji Lv
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Gut microbiota and health 3
- Ginseng Biological Effects and Applications 2
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Chemokine receptors and signaling 1
- Co-authors
- Yitao Jia (3 shared papers)Jian Lv (3 shared papers)Zhongxin Li (3 shared papers)Xinjian Xu (3 shared papers)Fang Guo (2 shared papers)Zhaolong Zhao (1 shared paper)Yang Li (1 shared paper)Feng Shi (1 shared paper)
- Journals
- PLoS ONE (2 papers)Current Protein and Peptide Science (1 paper)Journal of Cellular Biochemistry (1 paper)Cell Death and Disease (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- China
In The Last Decade
Ji Lv
10 papers receiving 538 citations
Peers
Comparison fields: 5 of 67
- Oncology 277
- Biological Psychiatry 21
- Immunology 133
- Hepatology 46
- Pharmacology 47
Countries citing papers authored by Ji Lv
This map shows the geographic impact of Ji Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Lv more than expected).
Fields of papers citing papers by Ji Lv
This network shows the impact of papers produced by Ji Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Lv. The network helps show where Ji Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 179 | |
| 2 | 2011 | 149 | |
| 3 | 2020 | 129 | |
| 4 | 2020 | 46 | |
| 5 | 2019 | 16 | |
| 6 | 2019 | 7 | |
| 7 | 2019 | 7 | |
| 8 | 2022 | 7 | |
| 9 | 2024 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2023 | 0 |
About Ji Lv
Ji Lv is a scholar working on Molecular Biology, Oncology, Surgery, Epidemiology and Rheumatology, having authored 11 papers that have together received 544 indexed citations. Recurring topics across this work include Gut microbiota and health (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Total Knee Arthroplasty Outcomes (2 papers), Ginseng Biological Effects and Applications (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Chemokine receptors and signaling (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Oncology (277 citations), Biological Psychiatry (21 citations), Immunology (133 citations), Hepatology (46 citations) and Pharmacology (47 citations). Ji Lv has collaborated with scholars based in China. Frequent co-authors include Yitao Jia, Jian Lv, Zhongxin Li, Xinjian Xu, Fang Guo, Zhaolong Zhao, Yang Li, Feng Shi, Hong Wang and Lin Zhou. Their work appears in journals such as PLoS ONE, Current Protein and Peptide Science, Journal of Cellular Biochemistry, Cell Death and Disease and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.